TY - JOUR
T1 - Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension - Relationship to tissue doppler indices of diastolic relaxation
AU - Tayebjee, Muzahir
AU - Nadar, Sunil
AU - Macfadyen, Robert
AU - Lip, Gregory
PY - 2004/9/1
Y1 - 2004/9/1
N2 - Background: Hypertension, hypertensive heart disease, and left ventricular (LV) hypertrophy are integral to symptomatic diastolic heart failure. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is linked to extracellular matrix fibrosis and is elevated in hypertension. We hypothesized a link between circulating TIMP-1, matrix metalloproteinase-9 (MMP-9), and resting echocardiographic LV filling parameters using tissue Doppler parameters of diastolic (dys)function.
Methods: Circulating MMP-9 and TIMP-1 levels were measured in citrated plasma by ELISA in 74 patients with hypertension (58 men, mean age 58 +/- 11 years) and 34 controls (23 men, mean age 53 +/- 13 years). All had confirmed normal short axis systolic contractility, with no significant wall motion abnormalities; the LV mass and standard resting tissue Doppler echocardiographic indices of diastolic function were also recorded.
Results: Both MMP-9 and TIMP-1 levels were higher in the hypertensive group (P = .0039 and P = .0054, respectively). When compared to controls, hypertensive patients had a greater LV mass (P = .0054), and differences in many of the parameters reflecting diastolic dysfunction (controls versus hypertensives: E: 0.71 +/- 0.15 v 0.81 +/- 0.15 m/sec, P = .004; A: 0.66 +/- 0.12 v 0.81 +/- 0.16 m/sec, P <.0001; e': 0.12 (0.09-0.14) v 0.09 (0.07-0.10) m/sec, P = .0017; e'/a': 1.20 (1.00-1.80) v 0.88 (0.71-1.05), P <.0001; E/e': 6.54 (4.75-7.14) v 8.89 (7.55-10.75), P <.0001, respectively). Within the hypertensive cohort, only TIMP-1 levels correlated with LV mass (r = 0.271, P = .024), LV mass index (r = 0.323, P = .007), and tissue Doppler parameters of diastolic dysfunction, including e' (r = -0.338, P = .005), a' (r = -0.350, P = .005), and E/e' (r = 0.334, P = .005).
Conclusions: TIMP-1 is thought to increase tissue concentrations of collagen type I by preventing its breakdown by MMPs. Our findings therefore add weight to a hypothesis suggesting that TIMP-1 may be a key mediator of LV diastolic dysfunction through definition of ventricular matrix composition. (C) 2004 American Journal of Hypertension, Ltd.
AB - Background: Hypertension, hypertensive heart disease, and left ventricular (LV) hypertrophy are integral to symptomatic diastolic heart failure. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is linked to extracellular matrix fibrosis and is elevated in hypertension. We hypothesized a link between circulating TIMP-1, matrix metalloproteinase-9 (MMP-9), and resting echocardiographic LV filling parameters using tissue Doppler parameters of diastolic (dys)function.
Methods: Circulating MMP-9 and TIMP-1 levels were measured in citrated plasma by ELISA in 74 patients with hypertension (58 men, mean age 58 +/- 11 years) and 34 controls (23 men, mean age 53 +/- 13 years). All had confirmed normal short axis systolic contractility, with no significant wall motion abnormalities; the LV mass and standard resting tissue Doppler echocardiographic indices of diastolic function were also recorded.
Results: Both MMP-9 and TIMP-1 levels were higher in the hypertensive group (P = .0039 and P = .0054, respectively). When compared to controls, hypertensive patients had a greater LV mass (P = .0054), and differences in many of the parameters reflecting diastolic dysfunction (controls versus hypertensives: E: 0.71 +/- 0.15 v 0.81 +/- 0.15 m/sec, P = .004; A: 0.66 +/- 0.12 v 0.81 +/- 0.16 m/sec, P <.0001; e': 0.12 (0.09-0.14) v 0.09 (0.07-0.10) m/sec, P = .0017; e'/a': 1.20 (1.00-1.80) v 0.88 (0.71-1.05), P <.0001; E/e': 6.54 (4.75-7.14) v 8.89 (7.55-10.75), P <.0001, respectively). Within the hypertensive cohort, only TIMP-1 levels correlated with LV mass (r = 0.271, P = .024), LV mass index (r = 0.323, P = .007), and tissue Doppler parameters of diastolic dysfunction, including e' (r = -0.338, P = .005), a' (r = -0.350, P = .005), and E/e' (r = 0.334, P = .005).
Conclusions: TIMP-1 is thought to increase tissue concentrations of collagen type I by preventing its breakdown by MMPs. Our findings therefore add weight to a hypothesis suggesting that TIMP-1 may be a key mediator of LV diastolic dysfunction through definition of ventricular matrix composition. (C) 2004 American Journal of Hypertension, Ltd.
KW - tissue Doppler
KW - extracellular matrix
KW - matrix metalloproteinase-9
KW - hypertension
KW - tissue inhibitor of metalloproteinase-1
KW - echocardiography
U2 - 10.1016/j.amjhyper.2004.06.023
DO - 10.1016/j.amjhyper.2004.06.023
M3 - Article
C2 - 15363818
SN - 1941-7225
VL - 17
SP - 770
EP - 774
JO - American Journal of Hypertension
JF - American Journal of Hypertension
IS - 9
ER -